Cargando…

Barriers to the Wider Use of Pre-exposure Prophylaxis in the United States: A Narrative Review

Antiretroviral pre-exposure prophylaxis (PrEP) to prevent HIV transmission was first approved by the US Food and Drug Administration in 2012. Despite correlations of decreases in new HIV infections being greatest where PrEP has been deployed, the uptake of PrEP is lagging, particularly among populat...

Descripción completa

Detalles Bibliográficos
Autores principales: Mayer, Kenneth H., Agwu, Allison, Malebranche, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467490/
https://www.ncbi.nlm.nih.gov/pubmed/32232664
http://dx.doi.org/10.1007/s12325-020-01295-0

Ejemplares similares